HEAD & NECK SURG MB 5 - Letter | 2022-06-12 00:00:00
  06/27/2022      ***** *****, MD  ***** ***** ***** ***** *****  ***** ***** ***** *****       UCSF Cancer Center Head and Neck Surgical Oncology Program ***** *****  ***** ***** ***** ***** *****  ***** ***** ***** *****-*****  Phone: *****-*****-*****  Fax: *****-*****-*****        ***** *****-***** *****, FACS (*****.*****-*****@*****.*****)    ***** *****. ***** *****, MPH (*****.*****@*****.***** )    ***** *****. ***** *****, FACS (*****.*****@*****.*****)    ***** *****. ***** ***** (*****.*****@*****.***** )    *****. ***** ***** MD, FACS (*****.*****.*****@*****.***** )    ***** *****. ***** *****, FACS (*****.*****@*****.***** )    ***** ***** *****, FACS (*****.*****@*****.***** )    ***** ***** *****, *****-C (*****.*****@*****.*****) Patient: ***** *****   ***** *****: *****   Date of Birth: 10/09/1954   Date of Visit: 06/12/2022       Dear Dr. *****:      It was my pleasure to see ***** ***** at the Head and Neck Surgical Oncology on 06/12/2022.    Below you will find my assessment and plan, as well as the complete note from our encounter.             Thank you for allowing us to participate in *****. *****'s care.      *****,      ***** ***** *****, MD    Electronically signed by ***** ***** *****, MD on 06/27/2022, 3:21 PM    *****  ***** *****  ***** *****, MD  ***** ***** *****, NP  ***** *****-***** *****, MD            HISTORY OF PRESENT ILLNESS  Identification:   ***** ***** is a 67 y.o. man with base of tongue cancer and bilateral lymphadenopathy. He was treated with primary chemoradiation at *****.     1.5 years since chemoradiation 70 Gy with weekly cisplatin 40 mg/m2 x 5 completed 12/23/2020.    Recent imaging studies  CT CHEST WITHOUT CONTRAST 01/23/2022  IMPRESSION:   No evidence of malignancy within the chest.    Report dictated by: ***** ***** *****, MD, signed by: ***** ***** *****, MD  Department of Radiology and Biomedical Imaging    CT NECK WITH CONTRAST: 10/03/2021   IMPRESSION:     1. Posttreatment changes without evidence of residual 
 primary mass at the right base of tongue.    2. Residual centrally necrotic right level IIb lymph node measures 8 x 5 mm, unchanged in size from prior PET/CT 03/27/2021 where it was not hypermetabolic. Continued attention on follow-up.    Report dictated by: ***** *****, MD, signed by: ***** ***** *****, MD PhD  Department of Radiology and Biomedical Imaging       Interval history:  Tightness in right greater than left neck. Plans to do PT for this at *****. *****'s. Eating a normal diet. Not bothered much by dry mouth    Here for follow up visit with no complaints other than dry mouth at times.    I, Dr. ***** *****, personally reviewed the notes from: ***** ***** *****, MD, 01/23/2022    *****, Dr. ***** *****, personally reviewed these scans on the day of clinic: CT CHEST 01/23/2022     Symptoms:     The patient denies any face pain, facial swelling, ear pain, facial weakness, facial numbness, shoulder weakness, dysphagia, odynophagia, hemoptysis, hoarseness, globus, or chronic cough.    MEDICATIONS  Current Medications       Dosage    fluoride, sodium, (***** 5000 BOOSTER PLUS) 1.1 % dental paste ***** TRACE AMOUNT ON TEETH TWICE DAILY. ***** OUT EXCESS. DO NOT EAT DRINK OR RINSE FOR 30 MINUTES.    multivitamin with minerals tablet Take by mouth    netarsudiL-latanoprost (*****) 0.02-0.005 % DROPSOLN     pilocarpine (SALAGEN) 5 mg tablet Take 1 tablet (5 mg total) by mouth 3 (three) times daily    zinc gluconate 50 mg tablet Take 50 mg by mouth daily          ALLERGIES  Allergies/Contraindications   Allergen Reactions    Glycopyrrolate Hives    Ondansetron Hcl        PHYSICAL EXAM  Vital Signs: BP 123/84  | Pulse 86  | Temp 37.1 C (98.7 F) (Tympanic)  | Resp 18  | Ht 172.3 cm (5' 7.84")  | Wt 71.9 kg (158 lb 9.6 oz)  | SpO2 100%  | BMI 24.23 kg/m    *****:  Well-appearing.  In no apparent distress.  Psychiatric: Alert and oriented to time, place, and person.   Eyes:  PERRLA, EOMI, sclera 
 white, no nystagmus.    Ears:  Normal pinnae.  Face:  No masses or lesions. Bilateral ***** full facial movement.   Oral cavity/oropharynx: Visually normal lips, teeth, gums, tongue, floor of mouth, buccal mucosa, tonsillar fossae, and base of tongue.  To palpation, normal soft floor of mouth, and tonsillar fossae bilaterally.  Normal tongue sensation bilaterally. No base of tongue mass.  Lymph/Neck: Radiation changes to neck. No palpable neck lymphadenopathy.  Trachea is midline.  No thyromegaly.   Muscles:  Full range of motion of neck and shoulders.   Neurological: Cranial nerves: November 01: intact  Skin: No rashes or suspicious lesions on the head, facial, or neck skin.    Procedure ordered/performed:   Flexible fiberoptic nasopharyngolaryngoscopy (***** *****: *****)   Medical necessity/Indication: base of tongue cancer  Needed full, in depth, and close up view of upper aerodigestive tract.     After obtaining informed consent from the patient, I inserted the endoscope through the oral cavity to view the oropharynx, hypopharynx, and larynx, which appeared normal.  The patient had normal bilateral symmetrical vocal cord movement.  The patient had normal inferior tonsillar fossae, base of tongue, vallecula, epiglottis, laryngeal epiglottis, ***** folds, arytenoids, false vocal cords, true vocal cords, piriform sinus, piriform sinus apices, posterior cricoid area, and posterior pharyngeal walls. Bilateral base of tongue free of tumor; there is normal mucosa.     ASSESSMENT  Currently no evidence of disease.    I, Dr. ***** *****, personally performed, reviewed, and interpreted the above reported ultrasound on the day of clinic.     I personally reviewed and interpreted the outside CT neck, MRI head and neck, PET/CT on the day of clinic with the following interpretation:     I discussed the diagnosis, above listed imaging scans/endoscopy, and the management plan listed below with the patient.      Significant 
 relevant past medical history: stage 3 chronic kidney disease  Karnofsky Performance Status *****: 90  ECOG status: 0  Blood thinners: none    Smoking history: nonsmoker    PLAN  Ct HPV DNA Drug test today.  Follow up in 4 months.      ***** *****. *****, MD  Associate Professor  Head and Neck Oncologic/Endocrine/Salivary Surgery  ***** ***** Hospital  ***** ***** Family Comprehensive Cancer Center  Department of Otolarygology-Head and Neck Surgery  UCSF Medical Center    *****, ***** *****, am acting as a scribe for services provided by ***** ***** *****, MD on *****/*****/***** *****:***** PM    The above scribed documentation as annotated by me accurately reflects the services I have provided.   ***** ***** *****, MD  *****/*****/***** *****:***** PM          

